Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 03 04:00PM ET
0.9361
Dollar change
-0.0639
Percentage change
-6.39
%
Index- P/E- EPS (ttm)-2.27 Insider Own- Shs Outstand6.53M Perf Week1.73%
Market Cap7.25M Forward P/E- EPS next Y-0.85 Insider Trans0.00% Shs Float5.67M Perf Month-14.12%
Income-12.84M PEG- EPS next Q-0.03 Inst Own17.65% Short Float5.58% Perf Quarter-17.89%
Sales35.36M P/S0.21 EPS this Y76.69% Inst Trans-43.16% Short Ratio0.11 Perf Half Y-9.99%
Book/sh0.85 P/B1.11 EPS next Y71.99% ROA-48.79% Short Interest0.32M Perf Year-75.04%
Cash/sh0.37 P/C2.52 EPS next 5Y- ROE-390.90% 52W Range0.61 - 4.00 Perf YTD-66.21%
Dividend Est.- P/FCF- EPS past 5Y7.90% ROI-219.29% 52W High-76.60% Beta0.37
Dividend TTM- Quick Ratio0.94 Sales past 5Y- Gross Margin45.35% 52W Low53.46% ATR (14)0.14
Dividend Ex-Date- Current Ratio1.53 EPS Y/Y TTM- Oper. Margin- RSI (14)51.83 Volatility13.65% 14.62%
Employees85 Debt/Eq0.18 Sales Y/Y TTM5.17% Profit Margin-36.30% Recom1.00 Target Price11.50
Option/ShortNo / Yes LT Debt/Eq0.06 EPS Q/Q78.84% Payout- Rel Volume0.10 Prev Close1.00
Sales Surprise-9.88% EPS Surprise-17.37% Sales Q/Q1.30% EarningsNov 13 AMC Avg Volume2.84M Price0.94
SMA208.56% SMA500.01% SMA200-19.56% Trades Volume292,362 Change-6.39%
Today 11:00AM
Nov-22-24 09:10AM
Nov-13-24 05:15PM
Nov-01-24 11:55AM
Oct-31-24 10:32AM
10:30AM Loading…
Oct-14-24 10:30AM
Oct-07-24 08:45AM
Sep-25-24 10:45AM
Aug-14-24 04:30PM
Aug-09-24 10:00AM
Jun-24-24 08:30AM
May-15-24 09:53PM
04:45PM
May-06-24 10:30AM
May-03-24 08:50AM
04:30PM Loading…
Mar-26-24 04:30PM
Mar-19-24 09:22AM
Mar-15-24 09:52PM
08:25PM
06:10PM
Mar-08-24 09:00AM
Feb-23-24 08:40AM
Feb-20-24 08:10AM
08:05AM
Feb-05-24 05:15PM
Feb-02-24 08:07AM
Jan-11-24 04:15PM
Nov-22-23 09:55AM
Nov-11-23 12:05PM
Nov-09-23 05:10PM
12:00PM Loading…
12:00PM
Nov-03-23 08:30AM
Oct-31-23 08:01AM
Oct-10-23 09:00AM
Oct-05-23 09:00AM
Oct-04-23 08:30AM
Aug-29-23 08:00AM
Aug-28-23 08:00AM
Aug-11-23 08:25AM
07:00AM
Aug-10-23 08:30AM
Aug-04-23 08:30AM
Jul-13-23 09:00AM
Jul-12-23 08:00AM
Jul-03-23 11:42AM
09:15AM
Jun-12-23 09:00AM
Jun-01-23 09:15AM
May-30-23 09:00AM
May-15-23 09:50AM
May-12-23 09:55AM
08:12AM
07:30AM
07:00AM
May-11-23 09:00AM
May-09-23 09:00AM
Apr-28-23 10:00AM
Apr-26-23 10:00AM
Mar-27-23 08:00AM
Mar-17-23 01:30PM
Mar-11-23 07:50AM
Mar-10-23 02:25AM
Mar-09-23 08:20AM
Mar-08-23 04:03PM
Mar-02-23 09:00AM
Feb-22-23 08:00AM
Feb-15-23 08:00AM
Jan-24-23 10:27AM
Jan-09-23 01:00PM
08:00AM
Dec-16-22 08:30AM
Dec-06-22 10:18AM
Nov-30-22 02:08PM
Nov-28-22 11:05AM
Nov-21-22 08:48AM
Nov-16-22 06:39AM
Nov-14-22 10:05AM
08:45AM
Nov-10-22 11:52AM
Nov-08-22 04:45PM
Oct-31-22 08:55AM
Oct-24-22 07:45AM
Oct-20-22 11:40AM
Oct-18-22 10:30AM
Oct-14-22 08:40AM
Oct-12-22 02:00PM
Oct-05-22 05:00PM
Sep-29-22 10:04AM
Sep-27-22 06:21AM
Sep-26-22 08:30AM
Sep-13-22 08:30AM
Sep-06-22 10:31AM
Aug-18-22 11:05AM
Aug-17-22 08:02AM
Aug-12-22 08:33AM
Aug-04-22 08:30AM
Aug-01-22 11:00AM
Jul-27-22 08:45AM
Jul-12-22 08:00AM
Jun-09-22 09:44AM
Biofrontera, Inc. is a biopharmaceutical company, which engages in the commercialization of pharmaceutical products. It specializes in the treatment of dermatological conditions, caused primarily by exposure to sunlight that results in sun damage to the skin. The company is focused on the treatment of actinic keratosis and markets a topical antibiotic for treatment of impetigo. Its products include Ameluz and Xepi, its two prescription drugs, and BF-RhodoLED, a lamp used with Ameluz, for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. The company was founded on March 3, 2015 and is headquartered in Woburn, MA.